Wang C et al. |
Combining metabolomics and network analysis to improve tacrolimus production in Streptomyces tsukubaensis using different exogenous feedings. |
2017 |
J. Ind. Microbiol. Biotechnol. |
pmid:28776273
|
Shahid S et al. |
Chronic hepatitis in the transplant patient. |
2017 |
Br J Hosp Med (Lond) |
pmid:28692371
|
Filipec Kanizaj T and Mijic M |
Inflammatory bowel disease in liver transplanted patients. |
2017 |
World J. Gastroenterol. |
pmid:28566881
|
Jin H et al. |
Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema. |
2017 |
J Dermatolog Treat |
pmid:27588441
|
Seo SR et al. |
Disrupted Skin Barrier is Associated with Burning Sensation after Topical Tacrolimus Application in Atopic Dermatitis. |
2017 |
Acta Derm. Venereol. |
pmid:28512670
|
Shen CL et al. |
Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft Rejection. |
2017 |
Sci Rep |
pmid:28512328
|
Egeland EJ et al. |
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation. |
2017 |
Transplantation |
pmid:28452920
|
Riva N et al. |
Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus. |
2017 |
Farm Hosp |
pmid:28236795
|
Sahutoglu T et al. |
Tac-MMF Versus CsA-MMF/CsA-AZA-Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation. |
2017 |
Transplant. Proc. |
pmid:28340811
|
Rebora A |
Tacrolimus and oral lichen planus: the question remains. |
2017 |
J Eur Acad Dermatol Venereol |
pmid:27324047
|
Størset E et al. |
The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation. |
2017 |
Br J Clin Pharmacol |
pmid:28146606
|
Dai Y et al. |
A case report of coup de sabre patient with hair transplantation. |
2017 |
J Dermatolog Treat |
pmid:28142293
|
Hashemizadeh Z et al. |
Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923870
|
Pensi D et al. |
First UHPLC-MS/MS method coupled with automated online SPE for quantification both of tacrolimus and everolimus in peripheral blood mononuclear cells and its application on samples from co-treated pediatric patients. |
2017 |
J Mass Spectrom |
pmid:28098395
|
Calvo PL et al. |
Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation. |
2017 |
Br J Clin Pharmacol |
pmid:28044353
|
Hayes W et al. |
Hypomagnesemia and increased risk of new-onset diabetes mellitus after transplantation in pediatric renal transplant recipients. |
2017 |
Pediatr. Nephrol. |
pmid:28039534
|
Wang L et al. |
Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis. |
2017 |
J. Neurol. |
pmid:28921038
|
Kalt DA |
Tacrolimus: A Review of Laboratory Detection Methods and Indications for Use. |
2017 |
Lab Med |
pmid:29096030
|
Andrews LM et al. |
Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients. |
2017 |
Expert Opin Drug Metab Toxicol |
pmid:29084469
|
Vanhove T et al. |
Pretransplant 4β-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation. |
2017 |
Br J Clin Pharmacol |
pmid:28603840
|